Tandem Diabetes Care (TNDM) Stock Price, News & Analysis

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tandem Diabetes Care in the last year. There are currently 1 sell rating, 6 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TNDM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TNDM, but not buy additional shares or sell existing shares.
View TNDM analyst ratings or view top-rated stocks.

12 Wall Street research analysts have issued 12-month price targets for Tandem Diabetes Care's shares. Their TNDM share price targets range from $21.00 to $62.00. On average, they anticipate the company's share price to reach $37.00 in the next twelve months. This suggests a possible upside of 12.3% from the stock's current price.
View analysts price targets for TNDM or view top-rated stocks among Wall Street analysts.

Tandem Diabetes Care's stock was trading at $29.58 at the beginning of the year. Since then, TNDM stock has increased by 11.4% and is now trading at $32.96.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our TNDM earnings forecast.

Tandem Diabetes Care will be holding an earnings conference call on Thursday, May 2nd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) issued its earnings results on Wednesday, February, 21st. The medical device company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.23) by $0.04. The medical device company had revenue of $196.80 million for the quarter, compared to analysts' expectations of $204.86 million. Tandem Diabetes Care had a negative trailing twelve-month return on equity of 31.48% and a negative net margin of 29.77%.

ETFs with the largest weight of Tandem Diabetes Care (NASDAQ:TNDM) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Equipment ETF (XHE), Syntax Stratified SmallCap ETF (SSLY), Harbor Corporate Culture Small Cap ETF (HAPS), Invesco Nasdaq Future Gen 200 ETF (QQQS) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).

Tandem Diabetes Care's stock reverse split before market open on Tuesday, October 10th 2017. The 1-10 reverse split was announced on Monday, October 9th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Tandem Diabetes Care updated its first quarter 2024 earnings guidance on Wednesday, February, 21st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $175.0 million-$175.0 million, compared to the consensus revenue estimate of $186.1 million.

11 employees have rated Tandem Diabetes Care Chief Executive Officer John Sheridan on Glassdoor.com. John Sheridan has an approval rating of 88% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tandem Diabetes Care investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Micron Technology (MU), DexCom (DXCM), Netflix (NFLX), Block (SQ), Roku (ROKU), Lululemon Athletica (LULU) and PayPal (PYPL).

Tandem Diabetes Care's stock is owned by many different retail and institutional investors. Top institutional investors include Park Avenue Securities LLC (0.01%), 180 Wealth Advisors LLC (0.01%) and GAMMA Investing LLC (0.01%). Insiders that own company stock include Brian B Hansen, Christopher J Twomey, Christopher J Twomey, David B Berger, Dick Allen, Elizabeth Anne Gasser, James Leal, John F Sheridan, Kathleen Mcgroddy-Goetz, Kim D Blickenstaff, Leigh Vosseller, Mark Reinstra, Rebecca B Robertson, Rebecca B Robertson, Shannon Marie Hansen and Susan Morrison.
View institutional ownership trends.

Shares of TNDM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.